Mitochondrial DNA affects tau phosphorylation in aging and Alzheimer's disease
Alzheimer's & Dementia · 2025-07 · 21 (7)
DOI: 10.1002/alz.70390 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 01.07.2025. Verfasst von Riley E Kemna und 11 weiteren Autor:innen. Beteiligte Einrichtung: University of Kansas Alzheimer's Disease Research Center, Fairway, Kansas, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, tau Proteins, DNA, Mitochondrial, Cognitive Dysfunction. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, NCI NIH HHS, National Cancer Institute.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION Impaired mitochondrial function is seen in Alzheimer's disease (AD), but its role is unclear. Mitochondrial DNA (mtDNA) supports bioenergetic metabolism, but it is uncertain how it might influence AD neuropathology. METHODS We used cytoplasmic hybrid (cybrid) cell lines made from SH‐SY5Y cells expressing mtDNA from cognitively healthy (CH), mild cognitive impairment (MCI), or AD individuals to investigate the impact of mtDNA‐determined mitochondrial function on amyloid, tau, and neurodegeneration (ATN) markers. Cybrid measurements were correlated with cognition and brain morphometry. RESULTS Relative to cybrids expressing mtDNA from CH individuals, MCI and AD cybrids contained more phosphorylated tau‐217 (p‐tau217), p‐tau181, and total tau. Cybrid p‐tau217 correlated with plasma p‐tau217 from the mtDNA donor ( β = 0.605, p < 0.001). We observed negative relationships between cybrid p‐tau217 and cognition and brain morphometry. MCI and AD cybrid proteomes showed mitochondrial dysfunction. DISCUSSION mtDNA‐determined mitochondrial function affects cell physiology in AD‐relevant ways. Our study suggests that mtDNA affects ATN status and clinical state. Highlights Mitochondrial DNA (mtDNA)–determined mitochondrial function drives Alzheimer's disease (AD) hallmarks. Cytoplasmic hybrid outcomes associate with mtDNA‐donor clinical measures. Proteomic analyses indicate mitochondrial dysfunction in AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Kansas Alzheimer's Disease Research Center, Fairway, Kansas, USA.
- Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas, USA.
- The Mass Spectrometry and Proteomics Core, University of Kansas Medical Center, Kansas City, Kansas, USA.
- Department of Cancer Biology, University of Kansas Medical Center, Kansas City, Kansas, USA.
- Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, Kansas, USA.
- Department of Cell Biology and Physiology, University of Kansas Medical Center, Kansas City, Kansas, USA.
Förderung
- NIA NIH HHS
- NCI NIH HHS
- National Cancer Institute
- National Institute on Aging
Zitieren
APA
Kemna, R. E., Kueck, P. J., Honea, R., Clark, Z., Rekowski, M., Weidling, I., Mayfield, H., John, C. S., Burns, J., Wilkins, H. M., Swerdlow, R., & Morris, J. K. (2025). Mitochondrial DNA affects tau phosphorylation in aging and Alzheimer's disease. Alzheimer's & Dementia, 21(7). https://doi.org/10.1002/alz.70390
Vancouver
Kemna RE, Kueck PJ, Honea R, Clark Z, Rekowski M, Weidling I, et al. Mitochondrial DNA affects tau phosphorylation in aging and Alzheimer's disease. Alzheimer's & Dementia. 2025;21(7). doi:10.1002/alz.70390
BibTeX
@article{Kemna2025,
author = {Kemna, Riley E and Kueck, Paul J and Honea, Robyn and Clark, Zachary and Rekowski, Michaella and Weidling, Ian and Mayfield, Hana and John, Casey S and Burns, Jeffrey and Wilkins, Heather M and Swerdlow, Russell and Morris, Jill K},
title = {Mitochondrial DNA affects tau phosphorylation in aging and Alzheimer's disease},
journal = {Alzheimer's & Dementia},
year = {2025},
volume = {21},
number = {7},
doi = {10.1002/alz.70390}
}
EUVIMED